Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), announced that its leadership will present at two notable life sciences conferences in New York. Dr. Shankar Musunuri, Chairman, CEO, and Co-founder, will …
Ocugen to Highlight Clinical Developments at Upcoming Life Sciences Conferences Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) recently disclosed its first-quarter financial results for 2024, showcasing significant growth and strategic advancements. The company reported a revenue of $16.6 million, …
TELA Bio Reports Strong First Quarter Growth, Expands Product Portfolio Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced its participation in two key healthcare investor conferences this May in New York.
Verrica Pharmaceuticals to Present at Upcoming Investor Conferences Read More
MALVERN, PA — Meridian Bank has announced the recruitment of Christopher E. McDermott as its new Senior Vice President, Commercial Lending, marking a significant enhancement to its team dedicated to …
Meridian Bank Bolsters Commercial Lending Team with New Senior VP Appointment Read More
MALVERN, PA — In a recent disclosure, Pennsylvania-based biotech firm Neuronetics (NASDAQ: STIM) announced its first-quarter financial performance for 2024, revealing a promising 12% increase in revenue compared to the …
Neuronetics Boasts 12% Revenue Increase, Expands Depression Treatment Sector Read More
WAYNE, PA — Aclaris Therapeutics (NASDAQ: ACRS), a noted bio-pharmaceutical firm, has made public its financial results for the first quarter of 2024. The announcement was made amidst an outline …
Aclaris Therapeutics Announces Q1 2024 Financial Performance: Corporate Updates Shift Focus to Novel, Capital-Efficient Immuno-Inflammatory Therapies Read More
EXTON, PA — Innovative Solutions & Support, Inc. (NASDAQ: ISSC) is set to present at the upcoming Sidoti MicroCap Investor Conference, a virtual event scheduled for May 8-9, 2024.
Innovative Solutions & Support, Inc. to Showcase at Sidoti MicroCap Investor Conference Read More
BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) has unveiled hopeful results from its Maximum Tolerated Dose (MTD) study of Probudur™, a long-acting pain management drug, in Sprague-Dawley rats. Probudur, …
Virpax Pharmaceuticals’ Probudur Shows Promising Results in Pain Management Study Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a medical technology firm, awarded Restricted Stock Units (RSUs) equivalent to 55,650 shares of common stock to thirteen newly hired non-executive employees on …
Neuronetics Awards Stock Options to New Employees as Inducement Read More
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) today unveiled a strategic move to safeguard its stockholders by adopting a limited duration stockholder rights agreement, commonly referred to as a …
Galera Therapeutics Implements Stockholder Rights Plan to Shield Investor Interests Read More